Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7199728
[patent_doc_number] => 20050164915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 11/088934
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12492
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088934
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088934 | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin | Mar 22, 2005 | Abandoned |
Array
(
[id] => 826933
[patent_doc_number] => 07402599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Protein structures and protein fibres'
[patent_app_type] => utility
[patent_app_number] => 11/079139
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 7928
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11079139
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/079139 | Protein structures and protein fibres | Mar 14, 2005 | Issued |
Array
(
[id] => 7187754
[patent_doc_number] => 20050192227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Method for reducing the risk of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/069321
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8187
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069321
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069321 | Method for reducing the risk of cancer | Feb 28, 2005 | Abandoned |
Array
(
[id] => 9676884
[patent_doc_number] => 08815793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Polymeric compositions and related methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/068298
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 43
[patent_no_of_words] => 29039
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11068298
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068298 | Polymeric compositions and related methods of use | Feb 27, 2005 | Issued |
Array
(
[id] => 486661
[patent_doc_number] => 07217786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide'
[patent_app_type] => utility
[patent_app_number] => 11/055679
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 8280
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055679 | Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide | Feb 10, 2005 | Issued |
Array
(
[id] => 7051276
[patent_doc_number] => 20050187163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Methods for accelerating bone, cartilage, and connective tissue growth'
[patent_app_type] => utility
[patent_app_number] => 11/042924
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11407
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042924 | Methods for accelerating bone, cartilage, and connective tissue growth | Jan 23, 2005 | Abandoned |
Array
(
[id] => 6926454
[patent_doc_number] => 20050239710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Anti-aging and wound healing compounds'
[patent_app_type] => utility
[patent_app_number] => 11/031488
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18734
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 53
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031488 | Anti-aging and wound healing compounds | Jan 6, 2005 | Issued |
Array
(
[id] => 7180507
[patent_doc_number] => 20050124553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Peptide compositions for treatment of sexual dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/031898
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17713
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124553.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031898
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031898 | Peptide compositions for treatment of sexual dysfunction | Jan 6, 2005 | Issued |
Array
(
[id] => 7111699
[patent_doc_number] => 20050209155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'IGF-binding protein-derived peptide or small molecule'
[patent_app_type] => utility
[patent_app_number] => 11/031919
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19018
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209155.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031919 | IGF-binding protein-derived peptide or small molecule | Jan 5, 2005 | Abandoned |
Array
(
[id] => 7040291
[patent_doc_number] => 20050159335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Pharmaceutical administration form for peptides, process for its preparation, and use'
[patent_app_type] => utility
[patent_app_number] => 11/028875
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3516
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028875 | Pharmaceutical administration form for peptides, process for its preparation, and use | Jan 3, 2005 | Issued |
Array
(
[id] => 5126400
[patent_doc_number] => 20070238671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Isopeptide Gap Junction Modulators'
[patent_app_type] => utility
[patent_app_number] => 10/584373
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20865
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584373 | Isopeptide Gap Junction Modulators | Dec 22, 2004 | Abandoned |
Array
(
[id] => 5028903
[patent_doc_number] => 20070270350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions'
[patent_app_type] => utility
[patent_app_number] => 10/596198
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 36393
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596198 | Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions | Dec 22, 2004 | Abandoned |
Array
(
[id] => 7040360
[patent_doc_number] => 20050159359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods and compositions for derepression of IAP-inhibited caspase'
[patent_app_type] => utility
[patent_app_number] => 11/021517
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 123
[patent_no_of_words] => 27819
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159359.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021517 | Methods and compositions for derepression of IAP-inhibited caspase | Dec 22, 2004 | Abandoned |
Array
(
[id] => 4786151
[patent_doc_number] => 20080139480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Combination Of (A) N--4-(3- Pyridyl)-2-Pyrimidine-Amine And (B) At Least One Hypusination Inhibitor And The UseThereof'
[patent_app_type] => utility
[patent_app_number] => 10/583107
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6504
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583107 | Combination Of (A) N--4-(3- Pyridyl)-2-Pyrimidine-Amine And (B) At Least One Hypusination Inhibitor And The UseThereof | Dec 16, 2004 | Abandoned |
Array
(
[id] => 4501786
[patent_doc_number] => 07919578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'Methods and compositions for inhibition of BCL6 repression'
[patent_app_type] => utility
[patent_app_number] => 10/582662
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20126
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582662 | Methods and compositions for inhibition of BCL6 repression | Dec 15, 2004 | Issued |
Array
(
[id] => 7176418
[patent_doc_number] => 20050123592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Pharmaceutical compositions and methods for insulin treatment'
[patent_app_type] => utility
[patent_app_number] => 11/002858
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4483
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002858 | Pharmaceutical compositions and methods for insulin treatment | Dec 1, 2004 | Issued |
Array
(
[id] => 5219785
[patent_doc_number] => 20070161096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Process for recovering polyhydroxialkanoates (\"phas\") from cellular biomass'
[patent_app_type] => utility
[patent_app_number] => 10/596077
[patent_app_country] => US
[patent_app_date] => 2004-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14332
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596077
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596077 | Process for recovering polyhydroxialkanoates (“PHAsâ€) from cellular biomass | Nov 24, 2004 | Issued |
Array
(
[id] => 554402
[patent_doc_number] => 07160860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Use of interleukin-6 antagonists for the treatment of diseases characterized by high levels of aromatase'
[patent_app_type] => utility
[patent_app_number] => 10/988628
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3926
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988628 | Use of interleukin-6 antagonists for the treatment of diseases characterized by high levels of aromatase | Nov 15, 2004 | Issued |
Array
(
[id] => 4511670
[patent_doc_number] => 07910089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Sialogogue, oral composition and food product containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/579731
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3399
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579731 | Sialogogue, oral composition and food product containing the same | Nov 15, 2004 | Issued |
Array
(
[id] => 7228908
[patent_doc_number] => 20050255548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Protein scaffolds for antibody mimics and other binding proteins'
[patent_app_type] => utility
[patent_app_number] => 10/989723
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12281
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255548.pdf
[firstpage_image] =>[orig_patent_app_number] => 10989723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/989723 | Protein scaffolds for antibody mimics and other binding proteins | Nov 14, 2004 | Abandoned |